FOXOW — FOXO TECHNOLOGIES INC.
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1812360 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,168,036 | 2,633,823 | -276,851 | -1,451,973 | 45,786,134 | 65,896 | 36,150,020 |
| Dec 2025 | 4,430,972 | 2,049,008 | -1,489,534 | -9,415,845 | 44,577,873 | 207,453 | 33,501,573 |
| Sep 2025 | 3,548,352 | 1,480,963 | -1,070,625 | -1,876,066 | 52,093,776 | 628,557 | 31,958,323 |
| Jun 2025 | 5,218,373 | 3,243,048 | 585,999 | -522,021 | 50,019,356 | 321,789 | 36,341,517 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,105,424
Investing CF
$-659,601
Financing CF
$3,814,014
CapEx
$-151,116
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-226,096,712
Inventory
$188,565
Receivables
$3,910,423
ST Investments
—
EBIT TTM
$-9,946,992
Pretax Income TTM
$-13,464,340
Interest Exp TTM
$3,517,348
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,367,617 | -3,502,262 | -12,430,390 | 44,577,873 | 33,501,573 | — | -3,865,117 |
| Dec 2024 | 4,051,601 | -5,970,151 | -12,406,389 | 41,708,071 | 36,436,260 | — | -2,840,614 |
| Dec 2023 | 145,291 | -20,287,171 | -26,450,536 | 725,653 | 14,825,862 | — | -6,645,057 |
| Dec 2022 | 511,000 | -28,706,000 | -95,255,000 | 35,408,000 | 28,700,000 | — | -23,760,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $44.14B | $559.51 | — |
| IQV | IQVIA HOLDINGS INC. | $42.84B | $260.24 | — |
| INCY | INCYTE CORP | $25.94B | $127.98 | — |
| MEDP | Medpace Holdings, Inc. | $17.31B | $620.03 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.25B | $298.58 | — |
News headlines (Yahoo Finance, 1h cache)
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
2026-07-29 12:30 · Yahoo
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
2026-07-06 13:07 · Yahoo
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
2026-07-01 11:30 · Yahoo
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
2026-05-28 12:33 · Yahoo
FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities
2026-01-20 13:07 · Yahoo
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS
2025-12-15 13:07 · Yahoo
FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION
2025-09-22 12:17 · Yahoo
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
2025-09-11 11:42 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.